7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorderRecruitingPhase 32026-10-06NCT07428538
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 32026-07-02NCT06578247
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, acute myeloid leukemia, acute myeloid leukemia with mutated NPM1, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, myeloid sarcoma, neoplasm, sarcomaRecruitingPhase 12026-03-13NCT05735184
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesSolid Tumor MalignanciesRecruitingPhase 12026-03-03NCT06994806
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to RuxolitinibHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosisRecruitingPhase 32025-09-25NCT06479135
PROMs After PancreatectomyCysts, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pancreatic Cyst, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatitisRecruitingNot stated2025-09-15NCT07173257
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter StudyNeurologic Manifestations, Paralysis, Unilateral, Vocal Cord, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vocal Cord Paralysis, cranial nerve neuropathy, laryngeal disorder, nervous system disorder, otorhinolaryngologic disease, palsy, respiratory system disorder, vagus nerve disorderRecruitingNot applicable2025-02-06NCT05119842